Sheri Holmen, PhD

Sheri Holmen, PhD, associate professor, Department of Surgery, University of Utah School of Medicine, discusses options for treating brain metastases in melanoma. Holmen says that utilizing targeted therapies could potentially be the answer, though clinically-tested combinations have historically not done as well as clinicians had hoped. She adds that combinations are still on the table in terms of treating brain metastases in melanoma, both with other targeted therapies, as well as immunotherapies.

Videos

Holmen says that utilizing targeted therapies could potentially be the answer, though clinically-tested combinations have historically not done as well as clinicians had hoped.

Dr. Sheri Holmen on Finding the Appropriate Treatments for Brain Metastases in Melanoma

Sheri Holmen, PhD, associate professor, Department of Surgery, University of Utah School of Medicine, discusses treating metastases in melanoma. Holmen says the treatment of metastases in melanoma is currently the biggest unmet clinical need in melanoma, specifically brain metastases.

Holmen and her team of researchers came up with an in vivo model to examine the process of metastases and the biology behind why and how they occur. Holmen says the in vivo model is also useful in testing new therapies to either abate or cure the brain metastases.

Sheri Holmen, PhD, discusses treating metastases in melanoma. Holmen says the treatment of metastases in melanoma is currently the cancer's biggest unmet clinical need, specifically brain metastases. 

Sheri Holmen, PhD | Authors

Articles

Dr. Sheri Holmen on Finding the Appropriate Treatments for Brain Metastases in Melanoma

Dr. Sheri Holmen on Brain Metastases in Melanoma